The Department of Veterans Affairs is launching a clinical trial to evaluate whether GLP-1 medications Ozempic and Wegovy can help treat alcohol use disorder in veterans. The study could inform future VA treatment options and coverage decisions for substance use care.
Read full story at Air Force Times →Related Topics
va-health-careclinical-trialglp-1ozempicwegovyalcohol-use-disordersubstance-use-treatment